Report error Found 97 Enz. Inhib. hit(s) with all data for entry = 11575
Displayed 1 to 50 (of 97 total ) | Next | Last >>
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Human)
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair

















































